Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912376 · ClinicalTrials.gov registry record
A Study of a Device Used to Take Pictures of Skin Blood Flow
A clinical trial of Basal Blood Flow, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT03912376: Completed study of Basal Blood Flow, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03912376 is a study of Basal Blood Flow that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03912376, a study of Basal Blood Flow, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is see fi the hyperspectral camera system (HCS) can measure skin blood flow (perfusion and oxygenation) in healthy people.
Primary Outcome
Number of participants evaluated to measure blood flow and oxygenation in the brachial artery
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quest Hyperspectral Imaging System
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-04-05 |
| Est. Completion | 2024-09-23 |
What the finished NCT03912376 record still lists
NCT03912376 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 1 condition, with Basal Blood Flow appearing as the primary indexed condition, and to 1 intervention - of which Quest Hyperspectral Imaging System is the first listed.
NCT03912376 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03912376 about?
NCT03912376 is a clinical study titled "A Study of a Device Used to Take Pictures of Skin Blood Flow". The purpose of this study is see fi the hyperspectral camera system (HCS) can measure skin blood flow (perfusion and oxygenation) in healthy people.
What is the current status of trial NCT03912376?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2019-04-05. Estimated completion is 2024-09-23.
What conditions does trial NCT03912376 study?
This clinical trial studies the following conditions: Basal Blood Flow.
What interventions are being tested in trial NCT03912376?
The interventions under investigation include: Quest Hyperspectral Imaging System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03912376?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03912376 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI